7775.T
The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
Business. The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
Analyst recommendations
2 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
The company maintains a strong liquidity position, with cash and equivalents amounting to ¥2,995,993,000, which is supported by a current ratio of 2.47. This indicates the company has sufficient short-term assets to cover its short-term liabilities. The liquidity_fpt metric further supports this, showing a robust ability to meet short-term obligations without external financing.
Profitability metrics indicate a healthy return on equity of 14.6% and a return on assets of 9.82%. These figures are in line with the industry's preferred metrics, suggesting the company is effectively utilizing its equity and assets to generate returns. The operating income of ¥1,510,359,000 and net income of ¥1,097,620,000 further support the company's profitability.
The company's revenue is primarily concentrated in the healthcare services and equipment segment, with no disclosed geographic breakdown. This concentration may expose the company to specific market risks, but it also allows for focused operational efficiency and market penetration.
The company's growth trajectory is positive, with a strong recent performance reflected in the last actual EPS of ¥38.21, which exceeds the mean EPS estimate of ¥30.60. This suggests the company is outperforming analyst expectations and is likely to maintain or improve its growth in the coming fiscal year.
Risk factors for the company are currently low, with no immediate filing-based liquidity or dilution flags detected. The debt-to-equity ratio of 0.27 indicates a conservative capital structure, reducing the risk of financial distress. Additionally, the company has not issued any recent dilutive securities, maintaining a stable share count.
Recent events, including the latest financial filing and analyst estimates, show a positive outlook for the company. The mean recommendation from analysts is 2.00, indicating a "hold" rating, with one strong-buy and one hold recommendation. This suggests a cautious optimism among analysts regarding the company's future performance.
- The company has a strong liquidity position with a current ratio of 2.47 and significant cash reserves.
- Profitability metrics, including a 14.6% return on equity, indicate effective use of equity and assets.
- The company's revenue is concentrated in the healthcare services and equipment segment, with no disclosed geographic diversification.
- The company is outperforming analyst EPS estimates, suggesting strong recent performance.
- The company maintains a conservative capital structure with a low debt-to-equity ratio and no immediate dilution risks.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 30,60 |
| Revenue | —no estimate | —no estimate | 10,2B JPY |
| Operating income | —no estimate | —no estimate | —no estimate |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 7775.T Market data — financials · 2026-05-27
- Daiken Medical Co Ltd Market data — analyst estimates · 2026-05-27